Onderneming CytRx Corporation Other OTC
Aandelen
CYTR
US2328286081
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10-01-22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01-10-07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 17-03-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29-07-21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27-07-22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12-07-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 495 092 | 492 306 ( 99,44 %) | 0 | 99,44 % |
Bedrijfsgegevens
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,05% | 58,71 mld. | |
-2,02% | 41,31 mld. | |
+37,60% | 39,2 mld. | |
-10,22% | 27,4 mld. | |
+13,42% | 26,55 mld. | |
-21,60% | 18,98 mld. | |
+2,89% | 12,51 mld. | |
+22,40% | 11,94 mld. | |
+27,49% | 12,08 mld. |